Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup Analysis.
Saved in:
| Title: | Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup Analysis. |
|---|---|
| Authors: | Sunami K; National Hospital Organization Okayama Medical Center, Okayama, Japan., Ikeda T; Shizuoka Cancer Center, Shizuoka, Japan., Huang SY; National Taiwan University Hospital, Taipei, Taiwan., Wang MC; Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan., Koh Y; Seoul National University Hospital, Seoul, Republic of Korea., Min CK; Seoul St. Mary's Hospital, Seoul, Republic of Korea., Yeh SP; China Medical University Hospital, Taichung, Taiwan., Matsumoto M; National Hospital Organization Shibukawa Medical Center, Shibukawa, Japan., Uchiyama M; Japanese Red Cross Society Suwa Hospital, Nagano, Japan., Iyama S; Sapporo Medical University School of Medicine, Sapporo, Japan., Shimazaki C; Japan Community Health care Organization Kyoto Kuramaguchi Medical Center, Kyoto, Japan., Lee JH; Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea., Kim K; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Kaneko H; Japanese Red Cross Osaka Hospital, Osaka, Japan., Kim JS; Severance Hospital, Seoul, Republic of Korea., Lin TL; Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan., Campana F; Sanofi, Cambridge, MA., Tada K; Sanofi, Tokyo, Japan., Iida S; Nagoya City University Institute of Medical and Pharmaceutical Sciences, Nagoya, Japan., Suzuki K; Japanese Red Cross Medical Center, Tokyo, Japan. Electronic address: ken-suzuki@mtb.biglobe.ne.jp. |
| Corporate Authors: | ICARIA-MM study group |
| Source: | Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2022 Aug; Vol. 22 (8), pp. e751-e761. Date of Electronic Publication: 2022 Apr 08. |
| Publication Type: | Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35641409 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup Analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sunami+K%22">Sunami K</searchLink>; National Hospital Organization Okayama Medical Center, Okayama, Japan.<br /><searchLink fieldCode="AU" term="%22Ikeda+T%22">Ikeda T</searchLink>; Shizuoka Cancer Center, Shizuoka, Japan.<br /><searchLink fieldCode="AU" term="%22Huang+SY%22">Huang SY</searchLink>; National Taiwan University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Wang+MC%22">Wang MC</searchLink>; Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.<br /><searchLink fieldCode="AU" term="%22Koh+Y%22">Koh Y</searchLink>; Seoul National University Hospital, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Min+CK%22">Min CK</searchLink>; Seoul St. Mary's Hospital, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Yeh+SP%22">Yeh SP</searchLink>; China Medical University Hospital, Taichung, Taiwan.<br /><searchLink fieldCode="AU" term="%22Matsumoto+M%22">Matsumoto M</searchLink>; National Hospital Organization Shibukawa Medical Center, Shibukawa, Japan.<br /><searchLink fieldCode="AU" term="%22Uchiyama+M%22">Uchiyama M</searchLink>; Japanese Red Cross Society Suwa Hospital, Nagano, Japan.<br /><searchLink fieldCode="AU" term="%22Iyama+S%22">Iyama S</searchLink>; Sapporo Medical University School of Medicine, Sapporo, Japan.<br /><searchLink fieldCode="AU" term="%22Shimazaki+C%22">Shimazaki C</searchLink>; Japan Community Health care Organization Kyoto Kuramaguchi Medical Center, Kyoto, Japan.<br /><searchLink fieldCode="AU" term="%22Lee+JH%22">Lee JH</searchLink>; Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+K%22">Kim K</searchLink>; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kaneko+H%22">Kaneko H</searchLink>; Japanese Red Cross Osaka Hospital, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Kim+JS%22">Kim JS</searchLink>; Severance Hospital, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lin+TL%22">Lin TL</searchLink>; Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Campana+F%22">Campana F</searchLink>; Sanofi, Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Tada+K%22">Tada K</searchLink>; Sanofi, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Iida+S%22">Iida S</searchLink>; Nagoya City University Institute of Medical and Pharmaceutical Sciences, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Suzuki+K%22">Suzuki K</searchLink>; Japanese Red Cross Medical Center, Tokyo, Japan. Electronic address: ken-suzuki@mtb.biglobe.ne.jp. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22ICARIA-MM+study+group%22">ICARIA-MM study group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101525386%22">Clinical lymphoma, myeloma & leukemia</searchLink> [Clin Lymphoma Myeloma Leuk] 2022 Aug; Vol. 22 (8), pp. e751-e761. <i>Date of Electronic Publication: </i>2022 Apr 08. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101525386 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2152-2669 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221522669%22">21522669 </searchLink><i>NLM ISO Abbreviation: </i>Clin Lymphoma Myeloma Leuk <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35641409 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.clml.2022.04.005 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e751 Titles: – TitleFull: Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup Analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sunami K – PersonEntity: Name: NameFull: Ikeda T – PersonEntity: Name: NameFull: Huang SY – PersonEntity: Name: NameFull: Wang MC – PersonEntity: Name: NameFull: Koh Y – PersonEntity: Name: NameFull: Min CK – PersonEntity: Name: NameFull: Yeh SP – PersonEntity: Name: NameFull: Matsumoto M – PersonEntity: Name: NameFull: Uchiyama M – PersonEntity: Name: NameFull: Iyama S – PersonEntity: Name: NameFull: Shimazaki C – PersonEntity: Name: NameFull: Lee JH – PersonEntity: Name: NameFull: Kim K – PersonEntity: Name: NameFull: Kaneko H – PersonEntity: Name: NameFull: Kim JS – PersonEntity: Name: NameFull: Lin TL – PersonEntity: Name: NameFull: Campana F – PersonEntity: Name: NameFull: Tada K – PersonEntity: Name: NameFull: Iida S – PersonEntity: Name: NameFull: Suzuki K IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2022 Aug Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 2152-2669 Numbering: – Type: volume Value: 22 – Type: issue Value: 8 Titles: – TitleFull: Clinical lymphoma, myeloma & leukemia Type: main |
| ResultId | 1 |
